Why the study?
Does low-dose prasugrel improve platelet inhibition compared to clopidogrel in patients undergoing endovascular treatment of unruptured intracranial aneurysms?
Does low-dose prasugrel improve platelet inhibition compared to clopidogrel in patients undergoing endovascular treatment of unruptured intracranial aneurysms?
Low-dose prasugrel provides more effective and consistent platelet inhibition than clopidogrel when used as premedication for endovascular treatment of unruptured intracranial aneurysms.
No takes yet. Share an insight, caveat, or question.
Low-dose prasugrel was associated with fewer ischemic events than clopidogrel; supports randomized trials before changing practice in aneurysm embolization.
Ha et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: